Skip to main content

SCAPHO 150MG Injection ( NOVARTIS )-Buy SCAPHO 150MG Online at best Price in India- Myapplepharma

SCAPHO 150MG Injection

DESCRIPTION

Secukinumab belongs to monoclonal antibody which is a protein which recognises and connect to an inflammatory protein called Interleukin 17A (IL-17A). In patients with psoriatic arthritis and ankylosing spondylitis, the body’s immune system produces an increased amount of IL-17A which causes the symptoms such as swollen and painful joints
Scapho 150mg is a prescription drugs which is used under proper guidance of medical oncologist
Scapho 150mg injection
Scapho 150mg injection

INDICATION

Scapho 150mg indicated for the treatment of following condition
Plaque Psoriasis
Psoriatic arthritis
Ankylosing spondylitis.

DOSAGE

Plaque Psoriasis:
Starting dose: given 300 mg SC at weeks 0, 1, 2, 3, and 4
initially at week 8, administer 300 mg SC once monthly
For some patientsmay be acceptable containing dose of Scapho 150 mg
Psoriatic Arthritis : Indicated for adults with active psoriatic arthritis
Recommended dosage
Psoriatic arthritis for other patients, administer with or without a loading dosage by SC injection
Scapho 150mg injection with loading dose administrated 150 mg SC at weeks 0, 1, 2, 3, and 4 and q4wk thereafter
Scapho 150mg without loading dose administrated 150 mg SC q4wk.
Consider a dosage of 300 mg, if a patient continues to have active psoriatic arthritis
May be administered with or without methotrexate.
Ankylosing Spondylitis:
Given with or without a loading dosage by SC injection
Scapho 150mg with loading dose is administrated 150 mg SC at weeks 0, 1, 2, 3, and 4 and q4wk thereafter
Scapho 150mg injection without a loading dose is administrated150 mg SC q4wk

MECHANISM

Secukinumab mechanism as Interleukin-17A (IL-17A) is a cornerstone cytokine (messenger protein) contains in the development of psoriasis and is found in peak concentrations in psoriasis plaques.
Secukinumab consist of human IgG1 monoclonal antibody which selectively binds to IL-17A, rapidly prohibiting its pro-inflammatory effects.

ADME

Maximum plasma concentration for single dose is 6 days and weekly dosing for first month is 31-34 days
Volume of distribution is 7.1 – 8.6 (IV administration)
The drug scapho is Metabolized via intracellular catabolism.
Scapho 150mg has half-life is 22-31 days

PRECAUTION

Scapho 150mg injection may have high risk of infections; use with caution in patients with chronic infection or a history of recurrent infection
Before to initiation of Scapho 150mg, start with anti-TB therapy in patients with a history of latent or active TB in whom an adequate course of treatment cannot be confirmed
May infuriate Crohn disease
Anaphylaxis and cases of urticaria resulted; if this appears, discontinue Scapho 150mg injection immediately and start anaphylaxis treatment

DRUG INTERACTION

Live vaccinations combination with Scapho 150mg should be avoided
CYP450 substrates concomitant use with Scapho 150mg injection may altered by increased levels of certain cytokines.

CONTRAINDICATION

Patients having Serious hypersensitivity reactions to the active substance or to any of the excipients

STORAGE

Store the drug at 2℃ to 8℃.

MISSED DOSE

In case of missed dose, patients must consult with medical practitioner and follow the instructions given by them.
thereby missed dose should be avoid and follow the regular dosing schedule.

SIDE EFFECTS

• Infections
• Nasopharyngitis
• Diarrhea
• URT infection
• Rhinitis
• Oral herpes
• Pharyngitis
• Urticaria
• Rhinorrhoea

Address:

Apartment No.304 A Wing,

Shiva Sakthi chs lts,

JP Road, Near Apna Bazar,

Andheri(West),

Mumbai - 400058

Maharashtra.

Ph number:

+91-9987711567

Mail id:

applepharamaceutical@gmail.com
Labels:

Comments

Post a Comment

Popular posts from this blog

Rozel 60mg injection dose, tablet | Apple pharmaceuticals

Rozel 60mg injection DESCRIPTION Rozel 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. Rozel 60mg injection PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. DOSAGE Fo
Post a Comment
Read more

Enzamide 40mg capsules (Enzalutamide) Uses & Side effects|Apple pharmaceuticals

Enzamide 40mg capsules DESCRIPTION Enzamide 40mg is a hormonal therapy, for men who are all affected with prostate carcinoma in metastatic stage. Enzamide 40mg capsule are majorly indicated for prostate carcinoma, which contains Enzalutamide, as an active component considered as non steroidal anti-androgen medication. Enzamide 40mg is involved in association with castration in the therapy of metastatic or long lasting castration resistant prostate cancer. Enzamide 40mg is a prescription medicine, the main ingredient which is used as Enzalutamide , only prescribed by medical oncologist. Enzamide 40mg capsule CAPSULES INDICATIONS The primary usage of Enzamide 40mg capsule is involved in the effective treatment of mCRPC (metastatic castration resistant prostate cancer), taken orally. The effect of anti-androgen viewing by obstruct the testosterone production by inhibiting androgen synthesis, the hormone which is require for cancer cell growth. Enzamide 40mg is ma
Post a Comment
Read more

Olimab 60mg injection | Denosumab |Apple pharmaceuticals

Olimab 60mg injection DESCRIPTION Olimab 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. Olimab 60mg injection PRESCRIBED Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. DOSA
Post a Comment
Read more